Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review
Multidisciplinary Respiratory Medicine · 04.07.2025 · 20 (Vol. 20 (2025))
DOI: 10.5826/mrm.2025.1030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multidisciplinary Respiratory Medicine, erschienen am 04.07.2025. Verfasst von Karolina Kėvelaitienė und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1 Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Vilnius University Faculty of Medicine, Vilnius, Lithuania; 2…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Tuberculosis (TB), induced by Mycobacterium tuberculosis, is a significant global health concern. It affects approximately 25% of the global population and ranks among the primary causes of mortality from infectious diseases. Notwithstanding progress, TB treatment and diagnosis continue to encounter substantial obstacles, such as restricted access to precise diagnostics and efficacious therapies. By 2035, international objectives seek to diminish tuberculosis-related fatalities by 95% and enhance treatment accessibility. Multiple factors affect the success of TB treatment, including personal behaviors, social and demographic circumstances, and concurrent health conditions. Critical risk factors for suboptimal treatment outcomes encompass low body mass index, tobacco use, substance abuse, and various demographic variables, including gender, age, unemployment, geographic location, and migration status. Co-infections with HIV, diabetes, chronic kidney disease, and COVID-19 are associated with increased rates of treatment failure. Supplementary challenges, including loss to follow-up and drug-resistant TB, elevate the probability of treatment failure. This review’s findings intend to furnish essential insights for policymakers, healthcare professionals, and TB control programs, enhancing strategies and interventions. The primary objective is to improve the efficacy of TB management globally, with an emphasis on attaining superior treatment outcomes, particularly in the most underserved regions.
Autor:innen und Institutionen
- 1 Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Vilnius University Faculty of Medicine, Vilnius, Lithuania; 2 Centre of Pulmonology and Allergology, Vilnius University Hospital Sa…
- Programs and Tuberculosis State Information System Department, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
ORCID-Profile: Karolina Kėvelaitienė, Edvardas Danila
Zitieren
APA
Kėvelaitienė, K., Davidavičienė, V. E., & Danila, E. (2025). Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review. Multidisciplinary Respiratory Medicine, 20(Vol. 20 (2025)). https://doi.org/10.5826/mrm.2025.1030
Vancouver
Kėvelaitienė K, Davidavičienė VE, Danila E. Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review. Multidisciplinary Respiratory Medicine. 2025;20(Vol. 20 (2025)). doi:10.5826/mrm.2025.1030
BibTeX
@article{Kvelaitien2025,
author = {Kėvelaitienė, Karolina and Davidavičienė, Valerija Edita and Danila, Edvardas},
title = {Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review},
journal = {Multidisciplinary Respiratory Medicine},
year = {2025},
volume = {20},
number = {Vol. 20 (2025)},
doi = {10.5826/mrm.2025.1030}
}
EUVIMED